Search
-
Embracing Mixed Mode Research
Why Mixed Mode is more than just a plan B and the way to future-proof your research studies.
-
First Impressions Matter
Understanding the power of spontaneous reactions to develop stronger innovations
-
Ipsos Update – February 2021
Our monthly round-up of the latest research and thinking from Ipsos around the world includes new global surveys on life during the pandemic, a new white paper on quality in market research and special features on US and French society.
-
How to drive sustainable brand growth?
A discussion on Ipsos’ view on the importance of brand tracking research, knowledge of consumer decision-making and fundamentals for brand growth.
-
The implications of COVID-19 on our diet & health
Almost a third of people globally have gained weight during pandemic, despite awareness of link between obesity and COVID-19 outcomes.
-
The power of research panels
Ipsos has invested in a global network of online access research for the past 20 years to deliver the highest standard of research insights. We believe the future of quality market research will continue to depend on properly managed research panels.
-
45% of people globally are currently trying to lose weight
More than half of the global population would rather exercise more and/or eat more healthily, but not diet as the actions they would take when trying to lose weight. But from a dietary perspective, sugar is seen as the main component that people would look to reduce or eliminate to help with weight loss.
-
A Year in Review - 2020
This has been a year of momentous change – real and anticipated. As we pause to reflect at the end of the year, we present some Ipsos research highlights you may have missed during the dizzying events of 2020.
-
Tetra Pak launches 2020 Index based on Ipsos global study
New study reveals food safety-environment dilemma fostered by COVID-19 pandemic.
-
Global Vaccines Research
As the race to develop a COVID-19 vaccine continues at speed, the world faces many more questions than answers – not only about when we might have a vaccine, but who will get it first, how will they get it and are they willing to have it? And how far will it take us on the journey back to ‘normal’…?